Results 161 to 170 of about 10,368 (217)

Localized bullous pemphigoid masquerading as venous leg ulcers in a patient with chronic venous insufficiency. [PDF]

JAAD Case Rep
Perry A, Namazian S, Vu T, Mervis J.
europepmc   +1 more source

Integrated Immune, Epithelial and Lipid Pathways in NSAID‐Exacerbated Respiratory Disease

Clinical and Translational Allergy, Volume 16, Issue 8, August 2026.
ABSTRACT NSAID‐exacerbated respiratory disease (N‐ERD) is a chronic inflammatory disorder characterized by asthma, chronic rhinosinusitis with nasal polyps and respiratory reactions to cyclooxygenase‐1 inhibiting nonsteroidal anti‐inflammatory drugs (NSAID).
Piotr Szatkowski, Lucyna Mastalerz
wiley   +1 more source

Dupilumab Combined With House Dust Mite Allergen Immunotherapy for Atopic Dermatitis: A Systematic Review and Meta‐Analysis

Clinical and Translational Allergy, Volume 16, Issue 8, August 2026.
ABSTRACT Background Dupilumab is effective for moderate‐to‐severe atopic dermatitis (AD), but sustained disease control after treatment discontinuation remains challenging. House dust mite allergen immunotherapy (HDM‐AIT) may provide disease‐modifying effects in sensitized patients, but the added value of combining HDM‐AIT with dupilumab remains ...
Jiale Lian, Ling Ren, Jing Liang, Shuping Guo   +3 more
wiley   +1 more source

Comparative efficacy of pediatric atopic dermatitis treatments: a network meta-analysis highlighting dupilumab and pimecrolimus for SCORAD and EASI improvement. [PDF]

Front Immunol
Yang L, Hu R, Wang Y, He Y.
europepmc   +1 more source

Lack of Differences in the Pharmacokinetics of Therapeutic Monoclonal Antibodies Between Japanese and Non‐Japanese Individuals

The Journal of Clinical Pharmacology, Volume 66, Issue 8, August 2026.
Abstract Evaluation of the pharmacokinetics (PK) of new drugs in Japanese individuals is regularly requested by the Japanese regulatory agency prior to participation in global clinical trials or for bridging approaches for regulatory approval. However, the need for PK assessments in the Japanese population may be less compelling for monoclonal ...
Paridhi Gupta, Ashish Sharma, Bernd Meibohm   +2 more
wiley   +1 more source

Dissociated Biologic Responses Across the United Airway: A Case Report of Severe Asthma With Chronic Rhinosinusitis With Nasal Polyps and Eosinophilic Otitis Media

Respirology Case Reports, Volume 14, Issue 8, August 2026.
We report a case of severe asthma with chronic rhinosinusitis with nasal polyps and eosinophilic otitis media that was successfully controlled by switching biologic therapy from dupilumab to mepolizumab. Careful monitoring of disease activity and consideration of biologic switching may help achieve optimal control with currently available biologics ...
Tomoko Tajiri, Naoki Takemoto, Toshiya Minakata, Motohiko Suzuki, Yoshiyuki Ozawa, Hirotsugu Ohkubo   +5 more
wiley   +1 more source

Unmasking the Unseen: Dupilumab-Induced Sarcoidosis in a Young Patient-A Case Report. [PDF]

Case Rep Pulmonol
Issawy M, Bsoul N, Hakrush O, Igbaria A, Imtanis Y, Bieber A, Goldstein LH.   +6 more
europepmc   +1 more source

Characterization of Prurigo Nodules in Adults With Moderate‐To‐Severe Atopic Dermatitis in Japan: A 2‐Year Observational Study

The Journal of Dermatology, Volume 53, Issue 8, Page 1099-1114, August 2026.
ABSTRACT Clinical phenotypes of atopic dermatitis (AD) can vary, with some individuals displaying difficult‐to‐treat prurigo nodularis‐like lesions. We aimed to assess the real‐world disease burden and treatment course of Japanese adults with AD‐associated prurigo nodules (AD‐Pn) receiving conventional AD treatments.
Yoko Kataoka, Takafumi Etoh, Hidehisa Saeki, Norito Katoh, Satoshi Teramukai, Yuki Tajima, Kwinten Bosman, Marius Ardeleanu, Kazuhiko Arima   +8 more
wiley   +1 more source

Eosinophilic Granulomatosis With Polyangiitis (EGPA) Manifesting as Giant Cell Arteritis After Initiating Treatment With Dupilumab: An Unusual Clinical Presentation. [PDF]

Cureus
Zafar S, Medina E, Panesar R, Murthy VL.
europepmc   +1 more source

Extended‐Interval Dosing and Discontinuation of Dupilumab in Atopic Dermatitis: A Real‐World Retrospective Study

The Journal of Dermatology, Volume 53, Issue 8, Page 1179-1183, August 2026.
ABSTRACT This retrospective study evaluated the clinical courses and treatment patterns of 81 patients with atopic dermatitis (AD) treated with dupilumab at Hiroshima University Hospital. Patients were categorized into six groups based on their clinical outcomes, including those who continued treatment, achieved remission and discontinued, or ...
Ryo Saito, Wataru Sasaki, Haruka Watanabe, Momoka Hashimoto, Rina Kamigaki, Kento Nagiri, Akio Tanaka   +6 more
wiley   +1 more source